CUTR
|
Cutera, Inc.
|
0.23%
|
US
|
NASDAQ
|
BLFS
|
BioLife Solutions, Inc.
|
0.23%
|
US
|
NASDAQ
|
ANIP
|
ANI Pharmaceuticals, Inc.
|
0.23%
|
US
|
NASDAQ
|
TBPH
|
Theravance Biopharma, Inc.
|
0.22%
|
US
|
NASDAQ
|
CHRS
|
Coherus BioSciences, Inc.
|
0.22%
|
US
|
NASDAQ
|
BTAI
|
BioXcel Therapeutics, Inc.
|
0.22%
|
US
|
NASDAQ
|
AVXL
|
Anavex Life Sciences Corp.
|
0.22%
|
US
|
NASDAQ
|
ADMA
|
ADMA Biologics Inc
|
0.22%
|
US
|
NASDAQ
|
MIRM
|
Mirum Pharmaceuticals, Inc.
|
0.21%
|
US
|
NASDAQ
|
RAPT
|
RAPT Therapeutics, Inc.
|
0.20%
|
US
|
NASDAQ
|
CTIC
|
Cell Therapeutics, Inc.
|
0.20%
|
US
|
NASDAQ
|
CERS
|
Cerus Corporation
|
0.20%
|
US
|
NASDAQ
|
ALEC
|
Alector, Inc.
|
0.20%
|
US
|
NASDAQ
|
AGEN
|
Agenus Inc.
|
0.20%
|
US
|
NASDAQ
|
MCRB
|
Seres Therapeutics, Inc.
|
0.19%
|
US
|
NASDAQ
|
HSKA
|
Heska Corporation
|
0.19%
|
US
|
NASDAQ
|
BLUE
|
bluebird bio, Inc.
|
0.19%
|
US
|
NASDAQ
|
ANAB
|
AnaptysBio, Inc.
|
0.19%
|
US
|
NASDAQ
|
EBS
|
Emergent Biosolutions, Inc.
|
0.19%
|
US
|
NYSE
|
PTGX
|
Protagonist Therapeutics, Inc.
|
0.18%
|
US
|
NASDAQ
|